|

Ferric carboxymaltose Clinical Trials

1 actively recruiting trial

▼ -1 trial since July 2026

Also known as: FCM, IV Iron

Pipeline

Phase 3: 1

Top Sponsors

  • Jon Unosson1

Indications

  • Liver Disease1
  • Aortic Aneurysm1
  • Liver Metastases1
  • Pancreas Cancer1
  • Surgery1

Other1 trial

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.